Severe colitis following lincomycin and clindamycin therapy.
D000284:Administration, Oral; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D002648:Child; D002981:Clindamycin / Q000008:administration & dosage / Q000009:adverse effects*; D003092:Colitis / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D005260:Female; D006801:Humans; D008034:Lincomycin / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011351:Proctoscopy; D012709:Serum Albumin / Q000032:analysis; D012812:Sigmoidoscopy; D013997:Time Factors
D000974:Antibodies, Antinuclear; D012709:Serum Albumin; D002981:Clindamycin; D008034:Lincomycin